• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    3/31/23 11:46:10 AM ET
    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Finance: Consumer Services
    Finance
    Major Banks
    Finance
    Get the next $SNTG alert in real time by email

     

    On Friday, 93 stocks made new 52-week lows.

    Noteworthy Points From Today's 52-Week Lows:

    • Canopy Gwth (NASDAQ:CGC) was the largest, in terms of market cap, to set a new 52-week low.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) was the smallest company in terms of market cap to set a new 52-week low.
    • Ensysce Biosciences (NASDAQ:ENSC)'s stock moved significantly downwards, trading down 802.99% to reach a new 52-week low.
    • CXApp (NASDAQ:CXAI)'s stock bounced back the most, actually rising 0.01% after reaching its new 52-week low.

    On Friday, the following stocks broke to new 52-week lows:

    • Canopy Gwth (NASDAQ:CGC) stock hit a new 52-week low of $1.75. The stock was up 0.32% on the session.
    • Amerant Bancorp (NASDAQ:AMTB) stock hit a yearly low of $21.16. The stock was up 0.14% for the day.
    • Nikola (NASDAQ:NKLA) stock dropped to a yearly low on Friday of $1.15. Shares traded down 13.21%.
    • Great Southern Bancorp (NASDAQ:GSBC) shares set a new yearly low of $49.07 this morning. The stock was up 0.02% on the session.
    • Advantage Solutions (NASDAQ:ADV) stock set a new 52-week low of $1.56 on Friday, moving down 2.78%.
    • Heritage Commerce (NASDAQ:HTBK) shares set a new yearly low of $8.02 this morning. The stock was up 0.86% on the session.
    • Sharecare (NASDAQ:SHCR) shares hit a yearly low of $1.36. The stock was down 6.51% on the session.
    • First Community (NASDAQ:FCBC) stock achieved a new 52-week low on Friday morning, hitting $25.03 and moving up 0.36%.
    • Clover Health Investments (NASDAQ:CLOV) stock dropped to a yearly low on Friday of $0.82. Shares traded up 2.85%.
    • Tremor Intl (NASDAQ:TRMR) shares made a new 52-week low of $5.07 on Friday. The stock was up 0.39% for the day.
    • South Plains Financial (NASDAQ:SPFI) stock broke to a new 52-week low of $21.03 on Friday. Shares of the company traded up 1.13%.
    • Bank of Marin (NASDAQ:BMRC) stock hit a yearly low of $21.90. The stock was down 0.36% for the day.
    • Alerus Finl (NASDAQ:ALRS) stock hit a new 52-week low of $15.31. The stock was up 0.9% on the session.
    • Cano Health (NYSE:CANO) stock achieved a new 52-week low on Friday morning, hitting $0.76 and moving down 22.07%.
    • Kezar Life Sciences (NASDAQ:KZR) stock hit $3.12 on Friday morning, setting a new 52-week low for a change of up 2.37%.
    • Bankwell Finl Gr (NASDAQ:BWFG) stock hit a yearly low of $24.26. The stock was up 1.21% for the day.
    • Ocugen (NASDAQ:OCGN) stock achieved a new 52-week low on Friday morning, hitting $0.82 and moving up 3.72%.
    • Heron Therapeutics (NASDAQ:HRTX) stock hit a yearly low of $1.48. The stock was down 2.92% for the day.
    • YS Biopharma Co (NASDAQ:YS) shares moved down 9.31% on Friday to hit a new 52-week low of $1.82, drifting down 9.31%.
    • BP Prudhoe Bay (NYSE:BPT) shares were down 5.25% for the day, having made a 52-week low of $7.42.
    • Meta Materials (NASDAQ:MMAT) shares hit a yearly low of $0.41. The stock was up 1.56% on the session.
    • First Internet (NASDAQ:INBK) shares were up 0.66% for the day, having made a 52-week low of $16.35.
    • Investar Holding (NASDAQ:ISTR) shares fell to $13.89 on Friday, setting a new 52-week low with a shift of down 1.83%.
    • FLJ Group (NASDAQ:FLJ) stock drifted down 7.21% on Friday morning to hit a new 52-week low of $0.71.
    • Hanover Bancorp (NASDAQ:HNVR) shares reached a new 52-week low of $18.00 on Friday morning, moving up 0.82%.
    • Dragonfly Energy Hldgs (NASDAQ:DFLI) stock hit $2.54 on Friday morning, setting a new 52-week low for a change of down 4.46%.
    • Babylon Holdings (NYSE:BBLN) stock hit a yearly low of $4.61. The stock was up 0.41% for the day.
    • Arrival (NASDAQ:ARVL) stock set a new 52-week low of $0.13 on Friday, moving up 0.66%.
    • Veru (NASDAQ:VERU) shares were up 1.0% for the day, having made a 52-week low of $1.15.
    • Vinco Ventures (NASDAQ:BBIG) shares hit a yearly low of $0.31. The stock was up 0.28% on the session.
    • Finance of America (NYSE:FOA) stock hit $1.19 on Friday morning, setting a new 52-week low for a change of down 0.82%.
    • Virgin Orbit Holdings (NASDAQ:VORB) stock broke to a new 52-week low of $0.19 on Friday. Shares of the company traded down 40.75%.
    • Bioventus (NASDAQ:BVS) shares reached a new 52-week low of $0.80 on Friday morning, moving down 28.49%.
    • Enlivex Therapeutics (NASDAQ:ENLV) stock hit $3.36 on Friday morning, setting a new 52-week low for a change of up 1.72%.
    • JOANN (NASDAQ:JOAN) shares fell to $1.56 on Friday, setting a new 52-week low with a shift of down 7.1%.
    • Cyxtera Technologies (NASDAQ:CYXT) stock achieved a new 52-week low on Friday morning, hitting $0.34 and moving down 19.29%.
    • Jin Medical International (NASDAQ:ZJYL) shares set a new yearly low of $7.38 this morning. The stock was down 3.53% on the session.
    • Bed Bath & Beyond (NASDAQ:BBBY) stock hit a yearly low of $0.50. The stock was down 14.91% for the day.
    • Syros Pharmaceuticals (NASDAQ:SYRS) shares hit a yearly low of $2.61. The stock was down 3.31% on the session.
    • Advent Technologies Hldgs (NASDAQ:ADN) stock hit a yearly low of $0.94. The stock was down 15.38% for the day.
    • Praxis Precision Medicine (NASDAQ:PRAX) stock drifted up 1.42% on Friday morning to hit a new 52-week low of $0.79.
    • Chicken Soup for the Soul (NASDAQ:CSSE) stock hit a yearly low of $1.72. The stock was down 41.56% for the day.
    • HOOKIPA Pharma (NASDAQ:HOOK) stock broke to a new 52-week low of $0.70 on Friday. Shares of the company traded up 0.65%.
    • Fathom Digital Mfg (NYSE:FATH) shares hit a yearly low of $0.56. The stock was down 14.14% on the session.
    • Vicinity Motor (NASDAQ:VEV) shares moved down 10.04% on Friday to hit a new 52-week low of $0.70, drifting down 10.04%.
    • Chanson International (NASDAQ:CHSN) shares were up 0.81% for the day, having made a 52-week low of $1.86.
    • Checkpoint Therapeutics (NASDAQ:CKPT) shares made a new 52-week low of $1.85 on Friday. The stock was down 34.87% for the day.
    • SAB Biotherapeutics (NASDAQ:SABS) stock achieved a new 52-week low on Friday morning, hitting $0.40 and moving up 2.7%.
    • ICZOOM Group (NASDAQ:IZM) shares fell to $2.04 on Friday, setting a new 52-week low with a shift of down 5.48%.
    • CXApp (NASDAQ:CXAI) stock set a new 52-week low of $1.43 on Friday, moving up 0.01%.
    • SMX (Security Matters) (NASDAQ:SMX) stock dropped to a yearly low on Friday of $0.91. Shares traded down 2.11%.
    • Mangoceuticals (NASDAQ:MGRX) stock drifted down 7.59% on Friday morning to hit a new 52-week low of $1.28.
    • ENGlobal (NASDAQ:ENG) shares moved down 3.0% on Friday to hit a new 52-week low of $0.46, drifting down 3.0%.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares moved down 0.21% on Friday to hit a new 52-week low of $0.28, drifting down 0.21%.
    • Lucy Scientific Discovery (NASDAQ:LSDI) stock drifted down 5.31% on Friday morning to hit a new 52-week low of $1.03.
    • Atlis Motor Vehicles (NASDAQ:AMV) shares set a new 52-week low of $0.55. The stock traded down 2.9%.
    • Asset Entities (NASDAQ:ASST) stock dropped to a yearly low on Friday of $1.37. Shares traded down 3.45%.
    • Shapeways Hldgs (NYSE:SHPW) stock hit a yearly low of $0.31. The stock was down 20.5% for the day.
    • Future FinTech Gr (NASDAQ:FTFT) stock hit a yearly low of $1.04. The stock was up 1.89% for the day.
    • Infinity Pharmaceuticals (NASDAQ:INFI) shares moved down 5.78% on Friday to hit a new 52-week low of $0.16, drifting down 5.78%.
    • AEterna Zentaris (NASDAQ:AEZS) stock set a new 52-week low of $2.49 on Friday, moving down 7.09%.
    • Aridis Pharmaceuticals (NASDAQ:ARDS) shares made a new 52-week low of $0.31 on Friday. The stock was down 6.5% for the day.
    • Akari Therapeutics (NASDAQ:AKTX) shares were up 3.47% for the day, having made a 52-week low of $0.14.
    • Nogin (NASDAQ:NOGN) shares set a new yearly low of $2.57 this morning. The stock was down 22.87% on the session.
    • Jaguar Health (NASDAQ:JAGX) shares fell to $0.65 on Friday, setting a new 52-week low with a shift of down 4.52%.
    • Bit Brother (NASDAQ:BTB) shares hit a yearly low of $0.83. The stock was down 22.03% on the session.
    • OceanPal (NASDAQ:OP) shares were down 3.02% for the day, having made a 52-week low of $0.34.
    • Aptinyx (NASDAQ:APTX) stock hit a yearly low of $0.12. The stock was down 6.37% for the day.
    • Biolase (NASDAQ:BIOL) shares fell to $0.27 on Friday, setting a new 52-week low with a shift of down 4.73%.
    • mCloud Technologies (NASDAQ:MCLD) shares were down 13.81% for the day, having made a 52-week low of $0.30.
    • ENDRA Life Sciences (NASDAQ:NDRA) shares reached a new 52-week low of $2.20 on Friday morning, moving down 12.31%.
    • Charah Solns (NYSE:CHRA) stock hit $2.03 on Friday morning, setting a new 52-week low for a change of down 19.77%.
    • Marker Therapeutics (NASDAQ:MRKR) shares set a new 52-week low of $0.74. The stock traded down 4.92%.
    • Netcapital (NASDAQ:NCPL) shares reached a new 52-week low of $0.95 on Friday morning, moving down 0.39%.
    • Aileron Therapeutics (NASDAQ:ALRN) shares moved down 0.76% on Friday to hit a new 52-week low of $1.24, drifting down 0.76%.
    • Gaucho Group Holdings (NASDAQ:VINO) stock dropped to a yearly low on Friday of $0.91. Shares traded down 3.12%.
    • Tivic Health Systems (NASDAQ:TIVC) stock drifted down 11.05% on Friday morning to hit a new 52-week low of $0.15.
    • Sentage Hldgs (NASDAQ:SNTG) shares were down 7.56% for the day, having made a 52-week low of $1.55.
    • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares were down 3.74% for the day, having made a 52-week low of $2.03.
    • Harbor Custom Dev (NASDAQ:HCDI) stock hit a new 52-week low of $4.77. The stock was down 5.31% on the session.
    • SciSparc (NASDAQ:SPRC) shares hit a yearly low of $0.46. The stock was down 2.1% on the session.
    • Clearmind Medicine (NASDAQ:CMND) stock hit $1.17 on Friday morning, setting a new 52-week low for a change of down 5.42%.
    • Kiromic BioPharma (NASDAQ:KRBP) shares made a new 52-week low of $3.16 on Friday. The stock was up 3.63% for the day.
    • Mobiquity Technologies (NASDAQ:MOBQ) stock set a new 52-week low of $0.17 on Friday, moving down 4.28%.
    • ContraFect (NASDAQ:CFRX) stock dropped to a yearly low on Friday of $1.73. Shares traded down 17.3%.
    • Fresh Tracks Therapeutics (NASDAQ:FRTX) stock hit $0.66 on Friday morning, setting a new 52-week low for a change of down 3.64%.
    • G Medical Innovations (NASDAQ:GMVD) stock set a new 52-week low of $0.90 on Friday, moving down 42.96%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares hit a yearly low of $1.65. The stock was down 5.68% on the session.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares reached a new 52-week low of $0.30 on Friday morning, moving down 25.47%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $SNTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNTG
    $SPFI
    $SPRC
    $SYRS

    CompanyDatePrice TargetRatingAnalyst
    Bankwell Financial Group Inc.
    $BWFG
    2/2/2026$48.00 → $49.00Market Perform
    Hovde Group
    Praxis Precision Medicines Inc.
    $PRAX
    2/2/2026$282.00Equal Weight
    Wells Fargo
    First Internet Bancorp
    $INBK
    1/30/2026$26.00 → $29.00Outperform
    Hovde Group
    South Plains Financial Inc.
    $SPFI
    1/27/2026$47.00 → $49.00Outperform
    Hovde Group
    Alerus Financial Corporation
    $ALRS
    1/7/2026Outperform → Market Perform
    Hovde Group
    Akari Therapeutics plc
    $AKTX
    1/5/2026$1.00Buy
    Ladenburg Thalmann
    Alerus Financial Corporation
    $ALRS
    1/5/2026$27.00Outperform → Strong Buy
    Raymond James
    SAB Biotherapeutics Inc.
    $SABS
    12/19/2025$15.00Buy
    Guggenheim
    More analyst ratings

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Haspel Ahron H was granted 1,592 shares, increasing direct ownership by 6% to 29,035 units (SEC Form 4)

    4 - Hanover Bancorp, Inc. /MD (0001828588) (Issuer)

    2/6/26 6:01:10 PM ET
    $HNVR
    Major Banks
    Finance

    EVP & Chief Credit Officer Corbett Kevin was granted 2,198 shares, increasing direct ownership by 8% to 29,123 units (SEC Form 4)

    4 - Hanover Bancorp, Inc. /MD (0001828588) (Issuer)

    2/6/26 6:01:12 PM ET
    $HNVR
    Major Banks
    Finance

    Treasurer Copeland Rex A exercised 1,797 shares at a strike of $41.30 and sold $114,418 worth of shares (1,797 units at $63.67) (SEC Form 4)

    4 - GREAT SOUTHERN BANCORP, INC. (0000854560) (Issuer)

    2/6/26 4:54:33 PM ET
    $GSBC
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Risk Officer Bonnett Derek A bought $17,500 worth of shares (501 units at $34.93) (SEC Form 4)

    4 - FIRST COMMUNITY BANKSHARES INC /VA/ (0000859070) (Issuer)

    2/2/26 1:10:07 PM ET
    $FCBC
    Major Banks
    Finance

    Officer Iafigliola Carlos bought $21,739 worth of shares (1,000 units at $21.74), increasing direct ownership by 7% to 15,964 units (SEC Form 4)

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    1/30/26 5:09:39 PM ET
    $AMTB
    Major Banks
    Finance

    Director Almeida Odilon bought $101,083 worth of shares (4,816 units at $20.99), increasing direct ownership by 963% to 5,316 units (SEC Form 4)

    4 - Amerant Bancorp Inc. (0001734342) (Issuer)

    1/28/26 5:52:26 PM ET
    $AMTB
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    SEC Filings

    View All

    Mangoceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - MANGOCEUTICALS, INC. (0001938046) (Filer)

    2/6/26 4:30:23 PM ET
    $MGRX
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 8-K filed by Netcapital Inc.

    8-K - Netcapital Inc. (0001414767) (Filer)

    2/6/26 4:30:23 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    SEC Form S-3 filed by Canopy Growth Corporation

    S-3 - Canopy Growth Corp (0001737927) (Filer)

    2/6/26 4:15:52 PM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation

    Collaboration aims to leverage Polyrizon's advanced proprietary intranasal delivery platform to support clinical development of Clearmind's drug candidate proprietary MEAI Raanana, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon" or the "Company"), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that it has entered into a development agreement with Clearmind Medicine Inc. (NASDAQ:CMND) ("Clearmind"), a clinical‑stage biopharmaceutical company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems. Under this agreement, Polyr

    2/6/26 7:55:00 AM ET
    $CMND
    $PLRZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI

    Collaboration aims to enhance bioavailability and support clinical advancement of Clearmind's lead MEAI candidate for addiction-related and other CNS disorders Vancouver, Canada, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ:CMND), (FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that it has entered into a development agreement with Polyrizon Ltd. (NASDAQ:PLRZ) ("Polyrizon"), a pre-clinical-stage biotechnology company developing advanced intranasal delivery solutions. Under the agreement, Clear

    2/6/26 7:55:00 AM ET
    $CMND
    $PLRZ
    Biotechnology: Pharmaceutical Preparations
    Health Care

    South Plains Financial, Inc. Named One of America's Best Banks by Forbes

    LUBBOCK, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- South Plains Financial, Inc. (NASDAQ:SPFI) ("South Plains" or the "Company"), the parent company of City Bank ("City Bank" or the "Bank"), announced that it has been named one of the best banks in the country, ranking 7th on Forbes 17th annual list of America's Best Banks. The designation ranked City Bank as the top bank in Texas. Curtis Griffith, South Plains' Chairman and Chief Executive Officer, commented, "We are truly honored to be included on this prestigious list. This ranking reflects the dedication and impact of our employees at every level of our organization. Their commitment strengthens our bank, supports our customers, and enr

    2/5/26 4:15:00 PM ET
    $SPFI
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hovde Group reiterated coverage on Bankwell Financial Group with a new price target

    Hovde Group reiterated coverage of Bankwell Financial Group with a rating of Market Perform and set a new price target of $49.00 from $48.00 previously

    2/2/26 7:12:59 AM ET
    $BWFG
    Major Banks
    Finance

    Wells Fargo initiated coverage on Praxis Precision Medicines with a new price target

    Wells Fargo initiated coverage of Praxis Precision Medicines with a rating of Equal Weight and set a new price target of $282.00

    2/2/26 6:51:57 AM ET
    $PRAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hovde Group reiterated coverage on First Internet Bancorp with a new price target

    Hovde Group reiterated coverage of First Internet Bancorp with a rating of Outperform and set a new price target of $29.00 from $26.00 previously

    1/30/26 6:48:44 AM ET
    $INBK
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Leadership Updates

    Live Leadership Updates

    View All

    Hanover Bancorp, Inc. Announces the Addition of a New Chief Commercial Real Estate Lending Officer

    MINEOLA, N.Y., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Hanover Bancorp, Inc. (NASDAQ:HNVR) (the "Company"), the bank holding company for Hanover Community Bank (the "Bank" or "Hanover"), today announced the appointment of Mr. William J. Newham, III to the position of Executive Vice President and Chief Commercial Real Estate (CRE) Lending Officer. Mr. Newham brings a relationship-focused approach to Hanover, a key differentiator as consolidation across the banking industry has limited access to CRE lending. With over two decades of commercial real estate banking experience and deep knowledge of the Long Island and New York metro area markets, particularly Suffolk County, his appointment better p

    1/29/26 4:30:00 PM ET
    $HNVR
    Major Banks
    Finance

    Strive Announces the Completion of Semler Scientific Acquisition

    DALLAS, TX, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Strive, Inc. (NASDAQ:ASST) ("Strive") today announced the successful completion of the previously announced acquisition of Semler Scientific. Strive now holds approximately 12,797.9 bitcoin, becoming the #11 largest public corporate holder of bitcoin globally. Strive also announces the appointment of Avik Roy as Chief Strategy Officer of Strive. Mr. Roy's initial focus will be on Strive's intentions to monetize the operating business from the Semler Scientific subsidiary by expanding its mandate in early disease detection products.  Mr. Roy began his career in science at MIT and trained as a physician at Yale Medical School before joining Ba

    1/16/26 8:40:00 AM ET
    $ASST
    $SMLR
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy

    BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced the appointment of world-renowned neurologist and epilepsy authority Dr. Orrin Devinsky, M.D., as Head of Clinical Strategy, a newly created leadership role. Dr. Devinsky is widely regarded as one of the most influential physician-scientists of his generation in modern epilepsy and clinical neuroscience. Over a career spanning more than four decades, he has shaped the development of multiple transformative therapies, built enduring global research initiatives, and helped define t

    1/13/26 4:30:00 PM ET
    $PRAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Finance of America Companies Inc.

    SC 13D/A - Finance of America Companies Inc. (0001828937) (Subject)

    12/11/24 8:30:03 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Financials

    Live finance-specific insights

    View All

    Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

    MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, February 11, 2026, at 8:00 a.m. ET to discuss its fiscal 2026 first quarter financial results and to provide a business update. The audio webcast will be accessible under the Home page and Investors page of the Company's website at www.verupharma.com. To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru I

    2/4/26 8:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bed Bath & Beyond, Inc. Scheduled to Release Fourth Quarter & Full Year 2025 Financial Results

    Bed Bath & Beyond, Inc. (NYSE:BBBY) (the "Company"), owner of Bed Bath & Beyond, Overstock, buybuy BABY, and a blockchain asset portfolio, today announced that it is scheduled to release fourth quarter & full year 2025 financial results after the market closes on Monday, February 23, 2026. The Company has also scheduled a conference call and webcast to be held on Monday, February 23, 2026, at 4:30pm ET to discuss these results and take questions from participants during the live event. Questions may also be submitted to [email protected] in advance. Webcast and Replay Information To access the live webcast, visit investors.beyond.com. To participate in the conference call via telephone, p

    2/2/26 8:30:00 AM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    First Internet Bancorp Reports Fourth Quarter and Full Year 2025 Results

    - Net income of $5.3 million, diluted EPS $0.60 - - Company to hold earnings call today at 5pm ET - First Internet Bancorp (the "Company") (NASDAQ:INBK), the parent company of First Internet Bank (the "Bank"), announced today financial and operational results for the fourth quarter and fiscal year ended December 31, 2025. Key Business Updates Revenue Momentum: Strong growth in net interest income (up 29%) and fully-taxable equivalent ("FTE") net interest margin (now 2.30%) drove adjusted quarterly revenue up 21% year-over-year to $42.1 million1. When combined with well-managed expenses, adjusted pre-provision net revenue grew 66% year-over-year. Credit Trends: The provision for

    1/29/26 4:08:00 PM ET
    $INBK
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care